Time to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen. Ho MD, Yeo KJ, Eggener SE. Am J Clin Pathol 2023 Aug 28:aqad109. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ho MD, Yeo KJ, Eggener SE. Time to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen. Am J Clin Pathol 2023 Aug 28:aqad109. doi: 10.1093.
PMID: 37639675